Modest effects of dietary supplements during the COVID-19 pandemic: insights from 445 850 users of the COVID-19 Symptom Study app

Bano Louca, Ben Murray, Kerstin Klaser, Mark Graham, Mohsen Mazidi, Emily Leeming, Ellen J. Thompson, Ruth Bowyer, David A Drew, Ha-Long Nguyen, Jordi Merino, Maria F Gomez, Olatz Mompeo Masachs, Ricardo Costeira de Oliveira Costeira, Carole H. Sudre, Rachel Gibson, Claire Steves, Jonathan Wolf, Paul W. Franks, Sebastien OurselinAndrew T Chan, Sarah Berry, Ana M. Valdes, Philip C. Calder, Tim Spector, Cristina Menni

Research output: Contribution to journalArticlepeer-review

76 Citations (Scopus)

Abstract

Objectives Dietary supplements may ameliorate SARS-CoV-2 infection, although scientific evidence to support such a role is lacking. We investigated whether users of the COVID-19 Symptom Study app who regularly took dietary supplements were less likely to test positive for SARS-CoV-2 infection. Design App-based community survey. Setting 445 850 subscribers of an app that was launched to enable self-reported information related to SARS-CoV-2 infection for use in the general population in the UK (n=372 720), the USA (n=45 757) and Sweden (n=27 373). Main exposure Self-reported regular dietary supplement usage (constant use during previous 3 months) in the first waves of the pandemic up to 31 July 2020. Main outcome measures SARS-CoV-2 infection confirmed by viral RNA reverse transcriptase PCR test or serology test before 31 July 2020. Results In 372 720 UK participants (175 652 supplement users and 197 068 non-users), those taking probiotics, omega-3 fatty acids, multivitamins or vitamin D had a lower risk of SARS-CoV-2 infection by 14% (95% CI (8% to 19%)), 12% (95% CI (8% to 16%)), 13% (95% CI (10% to 16%)) and 9% (95% CI (6% to 12%)), respectively, after adjusting for potential confounders. No effect was observed for those taking vitamin C, zinc or garlic supplements. On stratification by sex, age and body mass index (BMI), the protective associations in individuals taking probiotics, omega-3 fatty acids, multivitamins and vitamin D were observed in females across all ages and BMI groups, but were not seen in men. The same overall pattern of association was observed in both the US and Swedish cohorts. Conclusion In women, we observed a modest but significant association between use of probiotics, omega-3 fatty acid, multivitamin or vitamin D supplements and lower risk of testing positive for SARS-CoV-2. We found no clear benefits for men nor any effect of vitamin C, garlic or zinc. Randomised controlled trials are required to confirm these observational findings before any therapeutic recommendations can be made.

Original languageEnglish
Pages (from-to)149-157
Number of pages9
JournalBMJ Nutrition, Prevention and Health
Volume4
Issue number1
DOIs
Publication statusPublished - 1 Jun 2021

Fingerprint

Dive into the research topics of 'Modest effects of dietary supplements during the COVID-19 pandemic: insights from 445 850 users of the COVID-19 Symptom Study app'. Together they form a unique fingerprint.

Cite this